FR2818908B1 - Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs - Google Patents

Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs

Info

Publication number
FR2818908B1
FR2818908B1 FR0017331A FR0017331A FR2818908B1 FR 2818908 B1 FR2818908 B1 FR 2818908B1 FR 0017331 A FR0017331 A FR 0017331A FR 0017331 A FR0017331 A FR 0017331A FR 2818908 B1 FR2818908 B1 FR 2818908B1
Authority
FR
France
Prior art keywords
restituting
medicament
compound
active ingredients
vivo active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0017331A
Other languages
English (en)
Other versions
FR2818908A1 (fr
Inventor
Jean Robert Rapin
Dominique Halbitte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dospharma
Original Assignee
Dospharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0017331A priority Critical patent/FR2818908B1/fr
Application filed by Dospharma filed Critical Dospharma
Priority to US10/465,994 priority patent/US20040058854A1/en
Priority to PCT/FR2001/004236 priority patent/WO2002053091A2/fr
Priority to CA002435483A priority patent/CA2435483A1/fr
Priority to RU2003123490/15A priority patent/RU2003123490A/ru
Priority to EP01990622A priority patent/EP1446161A2/fr
Priority to JP2002554042A priority patent/JP2004517106A/ja
Priority to NZ527207A priority patent/NZ527207A/en
Publication of FR2818908A1 publication Critical patent/FR2818908A1/fr
Priority to ZA200207757A priority patent/ZA200207757B/en
Application granted granted Critical
Publication of FR2818908B1 publication Critical patent/FR2818908B1/fr
Priority to US11/879,505 priority patent/US20080021015A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
FR0017331A 2000-12-29 2000-12-29 Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs Expired - Fee Related FR2818908B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0017331A FR2818908B1 (fr) 2000-12-29 2000-12-29 Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs
NZ527207A NZ527207A (en) 2000-12-29 2001-12-31 Use as medicine of a compound restoring active principles in vivo
CA002435483A CA2435483A1 (fr) 2000-12-29 2001-12-31 Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs
RU2003123490/15A RU2003123490A (ru) 2000-12-29 2001-12-31 Применение в качестве медикамента соединения, восстанавливающего активные начала in vivo
EP01990622A EP1446161A2 (fr) 2000-12-29 2001-12-31 Association medicamenteuse d'une biguanine (metformine) et d'arginine
JP2002554042A JP2004517106A (ja) 2000-12-29 2001-12-31 有効成分を生体内で回復させる化合物の薬剤としての使用
US10/465,994 US20040058854A1 (en) 2000-12-29 2001-12-31 Use as medicine of a compound restoring active principles in vivo
PCT/FR2001/004236 WO2002053091A2 (fr) 2000-12-29 2001-12-31 Association medicamenteuse d'une biguanine (metformine) et d'arginine
ZA200207757A ZA200207757B (en) 2000-12-29 2002-09-26 Use as medicine of a compound restoring active principles in vivo.
US11/879,505 US20080021015A1 (en) 2000-12-29 2007-07-18 Use as medicine of a compound restoring active principles in vivo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0017331A FR2818908B1 (fr) 2000-12-29 2000-12-29 Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs

Publications (2)

Publication Number Publication Date
FR2818908A1 FR2818908A1 (fr) 2002-07-05
FR2818908B1 true FR2818908B1 (fr) 2004-04-02

Family

ID=8858429

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0017331A Expired - Fee Related FR2818908B1 (fr) 2000-12-29 2000-12-29 Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs

Country Status (9)

Country Link
US (2) US20040058854A1 (fr)
EP (1) EP1446161A2 (fr)
JP (1) JP2004517106A (fr)
CA (1) CA2435483A1 (fr)
FR (1) FR2818908B1 (fr)
NZ (1) NZ527207A (fr)
RU (1) RU2003123490A (fr)
WO (1) WO2002053091A2 (fr)
ZA (1) ZA200207757B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200719916A (en) * 2005-04-12 2007-06-01 Psivida Inc HMGCoA reductase inhibitor combinations and uses thereof
WO2007016306A2 (fr) * 2005-08-01 2007-02-08 Psivida Inc. Composes inhibiteurs de l'enzyme de conversion de l'angiotensine- inhibiteurs de la hmgcoa reductase
PL2712913T3 (pl) * 2012-09-28 2017-01-31 The Procter And Gamble Company Zewnętrzny system strukturyzujący do kompozycji ciekłego detergentu do prania

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112954A (en) * 1988-02-26 1992-05-12 Neorx Corporation Method of enhancing the effect of cytotoxic agents
US6075121A (en) * 1990-05-15 2000-06-13 Chiron Corporation Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
US5648344A (en) * 1990-07-30 1997-07-15 Glycomed Incorporated Methods of treating inflammation using selection binding compounds
US5240693A (en) * 1991-05-01 1993-08-31 University Of New Mexico Image enhancement by coadministration of biomodulators and structurally modified imaging agents
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
FR2696740B1 (fr) * 1992-10-13 1994-12-30 Dospharma Sa Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments.
AU6803494A (en) * 1993-06-07 1995-01-03 British Technology Group Limited Anticancer compounds
ATE267798T1 (de) * 1994-01-28 2004-06-15 Univ Kentucky Res Found Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
JP4278863B2 (ja) * 1997-12-08 2009-06-17 ブリストル−マイヤーズ スクイブ カンパニー メトホルミンの新規塩および方法
AU3536299A (en) * 1998-04-29 1999-11-16 Sumitomo Pharmaceuticals Company, Limited Oral formulation comprising biguanide and an organic acid
FR2796551B1 (fr) * 1999-07-23 2003-07-25 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
US6624317B1 (en) * 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents

Also Published As

Publication number Publication date
NZ527207A (en) 2006-04-28
WO2002053091A2 (fr) 2002-07-11
RU2003123490A (ru) 2005-01-20
JP2004517106A (ja) 2004-06-10
US20080021015A1 (en) 2008-01-24
ZA200207757B (en) 2004-07-26
FR2818908A1 (fr) 2002-07-05
CA2435483A1 (fr) 2002-07-11
EP1446161A2 (fr) 2004-08-18
WO2002053091A3 (fr) 2004-06-10
US20040058854A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
WO1999020228A3 (fr) Desinfectant
EP1333796A4 (fr) Preparations dentifrices anhydres pour l'administration d'ingredients incompatibles
BRPI0516541A (pt) composição para cuidado pessoal contendo uma fase de limpeza e uma fase de benefìcio
UY27320A1 (es) Nuevas composiciones farmacéuticas
ZA200000603B (en) Use of stilbene derivatives substituted in position 3, as deodrorant active agents in cosmetic compositions.
HUP0301194A3 (en) Pharmaceutical compositions containing combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents and their use for the treatment of diabete mellitus
BR0015188A (pt) Composições farmacêuticas
DK0689516T3 (da) Emballager til foldede enkeltbrugsservietter,der tilvejebringer udfoldning
DE60236556D1 (de) Einwegspender für eine einzige Dosis
FR2811552B1 (fr) Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide
ATE279910T1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
AR030857A1 (es) Derivados nitroso de difenolaminas, composiciones farmaceuticas que los contienen y su uso en la preparacion de productos medicinales
HUP0300653A3 (en) Liquid composition formulations, containing herbicidal active ingredients preparing and use thereof
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
ATE322878T1 (de) Biotin enthaltende galenische formulierung
BRPI0412697A (pt) composições farmacêuticas que apresentam um revestimento expansìvel
ATE361122T1 (de) Zahnpflegemittel in portionskapseln
WO2002053122A3 (fr) Produit de soin de la peau contenant des retinoides et des phyto-oestrogenes sous forme de conditionnement a double compartiment
AU4647200A (en) Skin care compositions containing combination of skin care actives
FR2818908B1 (fr) Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
ES2194643T3 (es) (1r,2s,4r)-(-)-2-((2'-(n,n-dimetilamino)-etoxi))-2-(fenil)-1,7,7-tri(metil)-biciclo(2,2,1)heptano de elevada pureza, sus sales de adicion farmaceuticamente aceptables, su procedimiento de preparacion y los medicamentos que los contienen.
AU4647300A (en) Skin care compositions containing combination of skin care actives

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
ST Notification of lapse

Effective date: 20090831